National Methadone Conference 2001 Sponsored by American Methadone Treatment Association

Attention: This
presentation contains pictures and takes time to download. 

Please be patient!

Opioid Treatment in the 21st Century: Implementing the Vision

St. Louis

October 7-10, 2001

St. Louis Arch

Five YEAR PLAN AVAILABLE IN POLICY MAKERS LUNCHEON SECTION

 

Advocacy Events and Patient Participation

NAMA at AMTA Conference 2001

Sunday, October 7th

Pre-conference Meeting 9 A.M. to 5 P.M.
Unifying the Treatment Community
Moderator Todd Rosendale, Center for Substance Abuse Treatment
Speakers

  • Fred Christie, AFFIRM (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

(Sponsored by the Center for Substance Abuse Treatment)

The First Patients Advocates Illumination Award 4 P.M.
Chair Todd Rosendale, Center for Substance Abuse Treatment
Presented by Joycelyn Woods, NAMA

The Advocacy Coalition will present the first patient’s Advocates Illumination Award to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment.

Presented to Dr. Marc Shinderman and the Center for Addiction Problems

(Sponsored by the Center for Substance Abuse Treatment)

Welcome Reception 6 P.M.

Monday, October 8th

Opening Address 8 A.M.

Policy Makers Luncheon 11 A.M. to 1 P.M.

Chair Mark Parrino, American Methadone Treatment Association

The Policy Maker’s Luncheon is an invitation only event that is attended by the federal and state agencies and
organizational representatives (i.e. ASAM, NAMA). The luncheon was initiated as a way to get the regulatory bodies together for discussions prior to changes in the federal regulation.

(Sponsored by the American Methadone Treatment Association)

Poster Session 2 P.M. 

The
Hepatitis C POSTER SESSION IS AVAILABLE AS POWERPOINT PRESENTATION ONLY! 

DOWNLOAD HCV PowerPoint Presentation

Hepatitis C and the Methadone Patient              
Authors

  • Tony Scro, NAMA Board of Directors (Grievance Coordinator) and ABATE (President)
  • Rokki Baker, NAMA Board of Directors (Chapter Coordinator), NAMA Nor-Cal (President) and Santa Cruz Hepatitis C Task Force
  • John Finger, NAMA (Regional Director), TexNAMA (President)
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist),TexNAMA (Vice President)

NAMA Organizational Meeting 7 P.M.
Chairs
Jo Sotheran, NAMA Board of Directors (Treasurer)
Joycelyn Woods, NAMA Board of Directors (President)

Many organizations use the conference as an opportunity to meet and NAMA is no different. Twenty-six NAMA representatives from around the country met to discuss patient advocacy issues.

Tuesday, October 9th

Hot Topic Round Table 2 P.M.
Administrative Detox: Necessary Use or Abuse
Authors

  • Joe Neuberger, Delaware NAMA (President)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee

Award Banquet 8 P.M.

The first conference of the new millennium heralds the recognition and acceptance of patient advocacy. For the first time no less than three awards were presented to patient advocates recognizing their work.

Wednesday, October 10th

Workshop 8 A.M.
Past, Present and Future: A Selection of Unfinished Business in Methadone Treatment
Authors

  • Moderator, Howard Lotsof, NAMA Acting Membership Director
  • Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President)
  • Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

Press Conference 12 P.M.
Director Jeanne Henry, Office of Public Affairs, Sate of Missouri, Department of Mental Health

Patient Advocacy Interviews Organized by Norma Alexander, NAMA Media Director
Interviews

  • Joycelyn Woods, NAMA Board of Directors (President)
  • Howard Lotsof, NAMA Acting Membership Director
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist) and TexNAMA (Vice President)

Sponsored by State of Missouri, Department of Mental Health

Closing Address 12 P.M.

Smoozing Around The Conference

A quick photo album of the conference.

 

NAMA HOME PAGE

Similar Posts

  • Hepatitis C Committee

    Admin 10/16/2021

    Chair: Dr. P. Kishore, MD, MPH, CMA (Boston NAMA) Committee Members Paul Bowman, CMA  Cheri Jarvis, CMA  The HCV Committee was created to empower methadone patients through education and advocacy and to provide support for those that do test positive for Hepatitis C. What Is Hepatitis C? Hepatitis is an inflammation of the liver. Although…

  • Basic Pharmacology

    Admin 04/10/2023

    Pharmacology is the study (ology) of drugs (pharmacy). Psychopharmacology is the study of (ology) drugs (pharmacology/y) that produce their effects on the mind or brain (psycho or psyche). There are five basic classes of psycho-active drugs: 1) the opioids (i.e., heroin and methadone), 2) the stimulants (i.e., cocaine, nicotine), 3) the depressants (i.e., tranquilizers, antipsychotics,…

  • Methadone, HIV Infection and Immune Function by Herman Joseph

    Admin 04/18/2023

    Education Series Number 4 April 1994 Herman Joseph, Ph.D. was part of the original team that started methadone treatment at The Rockefeller University. His research and publications have had a major influence on methadone treatment. After leaving the research team at Rockefeller University Dr. Joseph started and administered a methadone clinic for patients on probation…

  • Methadone 101

    Admin 07/06/2022

    Course Readings Lesson 1: Brief History of Methadone Maintenance Treatment   A short introduction about how methadone started. The original team consisted of four and included Drs. Dole and Nyswander who were the investigators, Dr. Herman Joseph who did the statistics and Dr. Mary Jeanne Kreek who was a medical student at the time. Lesson 2: Methadone…

  • National Alliance of Methadone Advocates Inc 435 Second Avenue New York, NY 10010      

    Admin 09/21/2021

    Membership Application Name:   _______________________________________________________   Mr. ___  Ms. ___  Dr. ___ Organization:  __________________________________________________________________________ Title:  _____________________________________________  Degree(s):  ________________________ Address:  _____________________________________________________________________________ Address:  _____________________________________________________________________________ City:   __________________________________   State:   ____________   Postal Code:   _____________ Email:  ______________________________________  Country:   ________________________________ Home Phone: (____)___________________________   Work Phone:  (____)_______________________ Alternate Phone:  (____)________________________   Fax:  (____)______________________________ If you have email may we send you bulletin alerts electronically. (This will get bulletin alerts to you quicker than usual mail)   Yes  _____   No _____ Types of Membership $_______ Individual Membership   Dues: $25 a…

  • It’s Final – Official Passing of New Rule!

    Admin 01/01/2023

    The next few years will be important and exciting for methadone maintenance treatment. On May 17, 2001 the oversight of methadone was officially removed from the FDA and handed over to the Center for Substance Abuse Treatment. We are currently in a3-year transition period during which CSAT is slowly setting policy which includes accreditation of…